Skip to content

Randomized Controlled Trial of Shunt vs ETV/CPC for PIH in Ugandan Infants

Neurocognitive Outcomes and Changes in Brain and Cerebral Spinal Fluid (CSF) Volume After Treatment of Post-Infectious Hydrocephalus (PIH) in Ugandan Infants by Shunting Versus ETV/CPC

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01936272
Enrollment
100
Registered
2013-09-06
Start date
2013-05-27
Completion date
2026-10-01
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydrocephalus

Brief summary

Two treatment options exist for infant patients with hydrocephalus. Most patients are treated with a surgical procedure in which a shunt is inserted into the brain and abdomen. In recent years, however, another treatment has developed called Endoscopic Third Ventriculostomy (ETV) with Choroid Plexus Cauterization (ETV/CPC).This research study is being done to measure the results of these procedures in children less than six months of age who have hydrocephalus as the result of a brain infection, called post-infectious hydrocephalus, or PIH. This study will evaluate patients in more detail to measure brain growth and development.

Detailed description

World over, infants with hydrocephalus are mainly treated using a shunt, which is a device made of soft plastic tubing that moves extra fluid from the brain to the abdomen. Surgery is required to insert a shunt into the brain and the abdomen. In recent years, we have developed another treatment called Endoscopic Third Ventriculostomy (ETV) with Choroid Plexus Cauterization (ETV/CPC). This research study is being done to measure the results of these procedures in children less than six months of age who have hydrocephalus as the result of a brain infection, called post-infectious hydrocephalus, or PIH. This is the most common cause of hydrocephalus in Ugandan babies. This study will evaluate patients in more detail to measure brain growth and development. Children in the study will have special testing to measure developmental progress as well as special imaging to evaluate the progress of their brain growth.

Interventions

DEVICEChhabra Shunt Placement
PROCEDUREETV/CPC

Sponsors

Boston Children's Hospital
Lead SponsorOTHER
Penn State University
CollaboratorOTHER
The Hospital for Sick Children
CollaboratorOTHER
CURE Children's Hospital, Uganda
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
1 Days to 180 Days
Healthy volunteers
No

Inclusion criteria

* Infants less than 180 days (six months) old * Symptomatic hydrocephalus * Post-infectious Hydrocephalus based on clinical and CT parameters2 * Must be from the following Ugandan districts: Bugiri, Busia, Iganga, Jinja, Kampala, Kamuli, Kapchorwa, Katakwi, Kumi, Mayuge, Mbale, Mukono, Pallisa, Sironko, Soroti, and Tororo

Exclusion criteria

* Any patient with a scalp erosion or infection that would exclude the patient from shunt implantation * Any patient with ventricular loculations that would normally indicate the use of ventriculoscopy as an adjunct to shunt placement * Any patient with absence of any visible cortical mantle on the CT * Patients must be appropriate candidates for either surgical procedure - shunt placement alone or ETV/CPC

Design outcomes

Primary

MeasureTime frameDescription
Change of Age-normed Bayley Scales of Infant Development (BSID)-III scores12 months and 24 months post treatmentNeurocognition will be measured using the BSID-III Cognitive Scale. Change will be assessed at 24 months post treatment from baseline score (12 months post treatment).

Secondary

MeasureTime frameDescription
Brain Volume12 months, 24 months, 5 years, and 7-10 years post treatmentVolume unit of measure is cubic millimeters. Volume is measured using CT scans.
CSF Volume12 months, 24 months, 5 years, and 7-10 years post treatmentVolume unit of measure is cubic millimeters. Volume is measured using CT scans.
Vineland Adaptive Behavior Scales5 years and 7-10 years post treatmentThe primary purpose of the VABS is to assess the social abilities of school age children.

Countries

Uganda

Contacts

PRINCIPAL_INVESTIGATORBenjamin C Warf, MD

Boston Children's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 19, 2026